RecruitingPhase 3NCT07071519
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Sponsor: AbbVie
Phoenix, AZ · San Diego, CA · San Francisco, CA · +9 more sites
Phase 3 Ulcerative Colitis clinical trials
14 recruiting Phase 3 ulcerative colitis studies in the US. What trial phases mean
Other phases
RecruitingPhase 3NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Tucson, AZ · Coronado, CA · Murrieta, CA · +34 more sites
RecruitingPhase 3NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Anaheim, CA · Chula Vista, CA · Los Alamitos, CA · +21 more sites
RecruitingPhase 3NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Sponsor: Takeda
Phoenix, AZ · Loma Linda, CA · Orange, CA · +10 more sites
RecruitingPhase 3NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
San Francisco, CA · Hartford, CT · Atlanta, GA · +8 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Dothan, AL · Anaheim, CA · Beverly Hills, CA · +34 more sites
RecruitingPhase 3NCT07158242
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Sponsor: Hoffmann-La Roche
Aurora, CO · Hartford, CT · Tampa, FL · +5 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Bristol, CT · Ypsilanti, MI · Liberty, MO · +9 more sites
RecruitingPhase 3NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Sponsor: Janssen Research & Development, LLC
Atlanta, GA · Indianapolis, IN · +3 more sites
RecruitingPhase 3NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Chandler, AZ · Litchfield Park, AZ · Scottsdale, AZ · +53 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Peoria, AZ · Scottsdale, AZ · +115 more sites
RecruitingPhase 3NCT07686081
Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
Sponsor: Vanda Pharmaceuticals
Chula Vista, CA · Nashville, TN
RecruitingPhase 3NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Sponsor: Takeda
Phoenix, AZ · Loma Linda, CA · Orange, CA · +11 more sites
RecruitingPhase 3NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Sponsor: Takeda
Mobile, AL · Phoenix, AZ · Los Angeles, CA · +19 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.